Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)

NCT02101957 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT02101957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02101957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)
Lead sponsor
University Hospital, Angers
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2010
Completion date
Not reported
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

huntington's disease